{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:05:13Z","timestamp":1772183113489,"version":"3.50.1"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T00:00:00Z","timestamp":1329868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032220","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T17:12:42Z","timestamp":1329930762000},"page":"e32220","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Improving the MVA Vaccine Potential by Deleting the Viral Gene Coding for the IL-18 Binding Protein"],"prefix":"10.1371","volume":"7","author":[{"given":"Juliana","family":"Falivene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Paula","family":"Del M\u00e9dico Zajac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Fernanda","family":"Pascutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Maeto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Perdiguero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen E.","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Calamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Magdalena","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"ref1","first-page":"375","article-title":"[The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)].","volume":"167","author":"A Mayr","year":"1978","journal-title":"Zentralbl Bakteriol B"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.","volume":"244","author":"G Antoine","year":"1998","journal-title":"Virology"},{"issue":"Pt 5","key":"ref3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine.","volume":"79","author":"TJ Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes.","volume":"89","author":"G Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.","volume":"238","author":"MW Carroll","year":"1997","journal-title":"Virology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.","volume":"100","author":"IM Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.","volume":"74","author":"JC Ramirez","year":"2000","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.","volume":"428","author":"PL Earl","year":"2004","journal-title":"Nature"},{"key":"ref9","first-page":"2386","article-title":"[MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].","volume":"99","author":"H Stickl","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/vir.0.19701-0","article-title":"A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.","volume":"85","author":"M Mwau","year":"2004","journal-title":"J Gen Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.pmed.0010033","article-title":"A randomised, double-blind, controlled vaccine efficacy trial of DNA\/MVA ME-TRAP against malaria infection in Gambian adults.","volume":"1","author":"VS Moorthy","year":"2004","journal-title":"PLoS Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.","volume":"10","author":"H McShane","year":"2004","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ijc.20569","article-title":"Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.","volume":"113","author":"CL Smith","year":"2005","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1099\/vir.0.80646-0","article-title":"Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.","volume":"86","author":"C Staib","year":"2005","journal-title":"J Gen Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/vir.0.81417-0","article-title":"Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy.","volume":"87","author":"RH Clark","year":"2006","journal-title":"J Gen Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e24244","DOI":"10.1371\/journal.pone.0024244","article-title":"A Candidate HIV\/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses.","volume":"6","author":"J Garcia-Arriaza","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1099\/0022-1317-81-5-1223","article-title":"Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins.","volume":"81","author":"VP Smith","year":"2000","journal-title":"J Gen Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1099\/0022-1317-83-11-2833","article-title":"The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model.","volume":"83","author":"JA Symons","year":"2002","journal-title":"J Gen Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.","volume":"10","author":"D Novick","year":"1999","journal-title":"Immunity"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","article-title":"IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family.","volume":"103","author":"CA Dinarello","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.","volume":"161","author":"T Yoshimoto","year":"1998","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells.","volume":"378","author":"H Okamura","year":"1995","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18.","volume":"73","author":"JA Gracie","year":"2003","journal-title":"J Leukoc Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.164.6.3246","article-title":"A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response.","volume":"164","author":"TL Born","year":"2000","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","article-title":"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.","volume":"77","author":"PC Reading","year":"2003","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1016\/j.vaccine.2008.06.011","article-title":"Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.","volume":"26","author":"K Dai","year":"2008","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).","volume":"3","author":"MG Cottingham","year":"2008","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.","volume":"201","author":"DC Tscharke","year":"2005","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.4049\/jimmunol.178.11.6814","article-title":"Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.","volume":"178","author":"M Moutaftsi","year":"2007","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.172.10.6209","article-title":"Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.","volume":"172","author":"MM Gherardi","year":"2004","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/mi.2009.103","article-title":"Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination.","volume":"2","author":"M Manrique","year":"2009","journal-title":"Mucosal Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1099\/vir.0.81181-0","article-title":"Recombinant poxviruses as mucosal vaccine vectors.","volume":"86","author":"MM Gherardi","year":"2005","journal-title":"J Gen Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni1557","article-title":"Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes.","volume":"9","author":"HD Hickman","year":"2008","journal-title":"Nat Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e8159","DOI":"10.1371\/journal.pone.0008159","article-title":"Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice.","volume":"4","author":"V Abadie","year":"2009","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance.","volume":"22","author":"F Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2006.00384.x","article-title":"Programming, demarcating, and manipulating CD8+ T-cell memory.","volume":"211","author":"VP Badovinac","year":"2006","journal-title":"Immunol Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2009.08.004","article-title":"Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B.","volume":"146","author":"AM Rodriguez","year":"2009","journal-title":"Virus Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.vaccine.2006.11.051","article-title":"Generation and immunogenicity of novel HIV\/AIDS vaccine candidates targeting HIV-1 Env\/Gag-Pol-Nef antigens of clade C.","volume":"25","author":"CE Gomez","year":"2007","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652311795684731","article-title":"MVA and NYVAC as vaccines against emergent infectious diseases and cancer.","volume":"11","author":"CE Gomez","journal-title":"Curr Gene Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e12395","DOI":"10.1371\/journal.pone.0012395","article-title":"Immunogenic profiling in mice of a HIV\/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions.","volume":"5","author":"J Garcia-Arriaza","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20041442","article-title":"Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.","volume":"201","author":"J Stack","year":"2005","journal-title":"J Exp Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.0510462103","article-title":"A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.","volume":"103","author":"A Alejo","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","first-page":"516219","article-title":"Newborn mice vaccination with BCG.HIVA(2)(2)(2)+MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes.","volume":"2011","author":"N Saubi","journal-title":"Clin Dev Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/651561","article-title":"Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.","volume":"201","author":"MB Wilck","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1099\/vir.0.83018-0","article-title":"Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice.","volume":"88","author":"CE Gomez","year":"2007","journal-title":"J Gen Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.it.2011.01.004","article-title":"Cytokines and the inception of CD8 T cell responses.","volume":"32","author":"MA Cox","journal-title":"Trends Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.","volume":"27","author":"NS Joshi","year":"2007","journal-title":"Immunity"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"16601","DOI":"10.1073\/pnas.1003457107","article-title":"Differential effects of STAT5 and PI3K\/AKT signaling on effector and memory CD8 T-cell survival.","volume":"107","author":"TW Hand","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e2404","DOI":"10.1371\/journal.pone.0002404","article-title":"An IFN-gamma-IL-18 signaling loop accelerates memory CD8+ T cell proliferation.","volume":"3","author":"Y Iwai","year":"2008","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1128\/IAI.01315-08","article-title":"Interleukin-18-related genes are induced during the contraction phase but do not play major roles in regulating the dynamics or function of the T-cell response to Listeria monocytogenes infection.","volume":"77","author":"JS Haring","year":"2009","journal-title":"Infect Immun"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0092-8674(92)90274-G","article-title":"A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.","volume":"71","author":"A Alcami","year":"1992","journal-title":"Cell"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/vim.2011.0018","article-title":"Recombinant MVA Expressing Secreted Glycoprotein D of BoHV-1 Induces Systemic and Mucosal Immunity in Animal Models.","volume":"24","author":"MF Ferrer","journal-title":"Viral Immunol"},{"key":"ref54","first-page":"138","article-title":"[Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].","volume":"39","author":"MF Ferrer","year":"2007","journal-title":"Rev Argent Microbiol"},{"key":"ref55","author":"CN Earl PL","year":"1998"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/JVI.00427-06","article-title":"Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB\/c mice.","volume":"80","author":"DC Tscharke","year":"2006","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1099\/vir.0.19120-0","article-title":"IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.","volume":"84","author":"MM Gherardi","year":"2003","journal-title":"J Gen Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.4049\/jimmunol.162.11.6724","article-title":"IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.","volume":"162","author":"MM Gherardi","year":"1999","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.","volume":"204","author":"JR Almeida","year":"2007","journal-title":"J Exp Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.","volume":"281","author":"MR Betts","year":"2003","journal-title":"J Immunol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T03:00:40Z","timestamp":1713582040000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032220"}},"subtitle":[],"editor":[{"given":"Adriano","family":"Boasso","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032220","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.724164818.793546664","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}